Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Topical tofacitinib is effective and safe for treating alopecia areata.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

TA-Ado effectively promotes hair growth and reduces hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tridax procumbens, a weed, has various medicinal properties including wound healing and antibacterial effects.

Tofacitinib treatment is used for teenagers with alopecia areata.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

The drug combination was safe and showed promise in treating advanced tumors.